Accessibility Menu
Moolec Science logo

Moolec Science(NASDAQ) MLECW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-99%
5 Year-98%
1 Year+51%
1 Month-4%
$0.02
+0.00%
+0.00Today
Moolec Science last closing stock price
MetricPriceDate
Last closeUSD 0.022026-08-31
Moolec Science stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.022026-08-24
1 month-3.64%USD 0.022026-07-31
3 month-5.92%USD 0.022026-06-02
Year to date+174.14%USD 0.012025-12-31
1 year+51.43%USD 0.012025-08-29
3 year-59.75%USD 0.042023-09-01
5 year-97.52%USD 0.642021-09-01
Since inception-98.55%USD 1.102021-03-02

Moolec Science Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$7.83M

Net Income (TTM)

-$8.28M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.50 (Low)

Price

$0.02

Volume

151

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $0.16

Estimated Earnings Date

May 28, 2026

MLECW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Moolec Science

Moolec Science S.A. is a pioneering ingredient company that focuses on producing animal proteins within plants through an innovative technique known as Molecular Farming. This disruptive approach positions the company at the forefront of the alternative protein industry, leveraging the agricultural strengths of key crops like soybeans and peas.

Products and Services
  • Animal proteins generated through Molecular Farming
  • Innovative ingredients for food and beverage industries
  • Research and development in alternative protein solutions
Growth Outlook
  • Projected increase in demand for alternative proteins globally
  • Strategic partnerships to enhance product distribution
  • Expansion into new markets across the Americas and Europe
Financial Highlights
  • Recent quarterly revenue of $2.64 million, showing growth potential
  • Trailing twelve months (TTM) revenue of $10.5 million, indicating market traction
  • Operating expenses reflect ongoing investment in R&D and market expansion
Moolec Science S.A. operates in the biotechnology sector, emphasizing sustainable and innovative solutions to meet the growing demand for alternative proteins. The company's unique approach to producing animal proteins within plants not only addresses food security but also aligns with global sustainability goals. Established in 2008 and headquartered in Luxembourg, Moolec Science has expanded its operations across the United States, Europe, and South America, positioning itself as a key player in the alternative protein market. The recent financial performance indicates a commitment to growth, with significant investments in research and development aimed at enhancing product offerings and market reach.
AI Generated • Aug 5, 2026

Industry

Food Products

Headquarters

Grand Cayman, GT KY1-9009, KY

MLECW Financials

Key Financial Metrics (TTM)

Gross Margin

34.17%

Operating Margin

-3.14%

Net Income Margin

-33.41%

Return on Equity

376.84%

Return on Capital

-5.79%

Return on Assets

-54.45%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

151

Avg. Volume

36.56K

Financials (TTM)

Gross Profit

-$639.50K

Operating Income

-$9.14M

EBITDA

-$5.21M

Operating Cash Flow

-$5.70M

Capital Expenditure

-$419.96K

Free Cash Flow

-$6.12M

Cash & ST Invst.

$1.08M

Total Debt

$66.48M

Moolec Science Performance Analysis

Moolec Science sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-27.8%
Q12024-09-302.2%
Q22024-12-3169.7%
Q22025-12-31N/A
Moolec Science sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-75.0%
Q12024-09-3028.6%
Q22024-12-31-20.0%
Q22025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2024YOY CHG

Revenue

$2.64M

+948.3%

Gross Profit

-$674.37K

-7285.5%

Gross Margin

-25.52%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

52

N/A

Net Income

-$2.43M

-36.1%

EBITDA

-$1.15M

+33.5%

Quarterly Fundamentals

Name
Q2 2024YOY CHG

Total Cash

$1.08M

-74.7%

Total Debt

$66.48M

+378.6%

Accounts Receivable

$3.97M

+128.2%

Inventory

$3.99M

+930.1%

Long Term Debt

$12.03M

+10.3%

Short Term Debt

$54.45M

+1723.2%

Return on Assets

-54.45%

N/A

Return on Invested Capital

33.43%

N/A

Free Cash Flow

-$1.19M

+70.6%

Operating Cash Flow

-$890.48K

+78.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NRSNNeuroSense Therapeutics Ltd.
$0.43+1.50%
VIVSVivoSim Labs, Inc.
$0.29+2.14%
CYCNCyclerion Therapeutics, Inc.
$3.68-2.90%
TCRTAlaunos Therapeutics, Inc.
$1.70+5.92%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About MLECW

What is the current price of Moolec Science?

Moolec Science is trading at $0.02 per share.

What is the 52-week range for Moolec Science?

Over the past 52 weeks, Moolec Science has traded between $0.00 and $0.16.

How much debt does Moolec Science have?

Moolec Science total debt is unavailable.

How much cash does Moolec Science have on hand?

Moolec Science does not have cash on hand data available.

What is Moolec Science’s dividend yield?

Moolec Science does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.